RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Pre-hospital organization: The first links in the chain of survival for heart attack patients

Sep 1, 2009 - 4:00:00 AM
There are financial and political disincentives for the transfer of STEMI patients for balloon angioplasty: all of these factors should be addressed:

 
[RxPG] Barcelona, Spain, 1 September: Mortality rate following a heart attack has fallen by more than 50% in Europe over the past 25 years. However, because only minor advances in the medical treatment of AMI are expected over the next decade, it is through organisational changes in the pre-hospital phase that mortality rate will continue this decline to below 5%.

We estimate that acute coronary syndromes (ACS) account for 1.5 million hospital admissions throughout Europe each year. Almost half these patients present with ST-elevation myocardial infarction (STEMI), which are major and immediately life-threatening events.

Just 30 years ago, mortality of acute myocardial infarction (AMI, heart attack) in Europe was over 30%. This rate has now dropped dramatically to around 10% within the first month. In clinical trials - where the sickest patients are often excluded - mortality rate is as low as 5%.

This dramatic improvement was initially brought about by the opening of dedicated coronary care units in hospitals. This was followed by 20 years of drug development, and a significant improvement in survival rates. Among the important drugs introduced were those preventing blood from clotting, or even dissolving the clot responsible for blocking the coronary vessel (and so causing the AMI. Other drugs groups include beta-blockers, ACE inhibitors, and statins develeoped to lower cholesterol levels. More recently, the treatment of large heart attacks with balloon angioplasty has been a major advance. Although new and better drugs are being developed and drug combinations being refined, there is less belief in major drug breakthroughs in the next decade.

The pre-hospital phase of AMI treatment has also undergone several changes over the past decade: diagnosis, supported by telemedicine, has improved, and many interventions have been moved from the hospital to the field. It is in this early phase that we must now adopt new collaborations and organisations if mortality rate in this large patient population is to continue its decline. We must adopt new lean principles in the entire organisation of the pre-hospital phase, starting with public awareness of symptoms, and how to raise the alarm. For those patients whose first symptom is cardiac arrest, basic bystander resuscitation should become standard. Despite an abundance of automated external defibrillators (AED) in many regions, their localisation and use are often not well organised. Heart attack victims should call an emergency number, instead of being self or family-transported to the hospital.

There are financial and political disincentives for the transfer of STEMI patients for balloon angioplasty: all of these factors should be addressed:

Primary Hospital




Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)